NCT04704518View on ClinicalTrials.gov

Phase IV Study to Evaluate the Efficacy of Lagricel® Ofteno PF Compared to Thealoz® Duo After Photorefractive Keratectomy (PRK)

PHASE4CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

September 3, 2022

Primary Completion Date

December 22, 2023

Study Completion Date

December 22, 2023

Conditions
Photorefractive KeratectomyCorneal De-epithelialization
Interventions
DRUG

Sodium Hyaluronate Ophthalmic 0.4%

Topical ophthalmic administration of one drop of Lagricel® Ofteno PF QID.

DRUG

Trehalose 3% / Sodium Hyaluronate Ophthalmic 0.15%

Topical ophthalmic administration of one drop of Thealoz® Duo QID.

Trial Locations (1)

Unknown

Aris Vision Institute de Guadalajara, S. C., Guadalajara

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY